Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Adverse drug reactions reported to an ADR monitoring centre as a part of the Pharmacovigilance Programme of India: A retrospective analysis of 3-year data

Sai Nathan Ramnath, Parvathy V Nair, Melcy Mary Philip, Dhanya Sasidharan Palappallil.




Abstract

Background: Pharmacovigilance is an important element of evidence-based medicine generating data for rational use of drugs.

Aims and Objectives: The aims and objectives of the study are to describe the pattern of adverse drug reactions (ADRs) reported to an ADR monitoring centre (AMC).

Materials and Methods: This was a retrospective analysis of ADRs reported to an AMC in South Kerala for a period of 3 years from October 2017 to September 2020 after obtaining Institutional Ethics Committee clearance. The data were entered in Excel and analyzed using SPSS 16.

Results: During the period under study, 634 ADRs were reported with a mean age of 48.75 ± 19.25 years. The most common organ affected was skin and appendages followed by the hepatobiliary system. The most common ADRs reported were itching, maculopapular rash, and elevated liver enzymes. Antimicrobials accounted for the maximum ADRs of which beta-lactams were the most common. The median time for occurrence of ADRs was after 4 days (interquartile range: 1.30). The majority of ADRs were probable, preventable, had moderate severity, and non-serious. Skin and integumentary followed by hepatobiliary system were the most common ADRs and isoniazid was the most common drug associated with ADRs.

Conclusion: Antimicrobials accounted for the maximum number of ADRs which were dominated by beta-lactams and antituberculosis drugs. Prospective studies on the development of ADRs will give better understanding of the temporality as well as outcome and management of ADRs.

Key words: Adverse Drug Reactions; Pharmacovigilance; Causality; Preventability; Temporality; Severity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.